ALA 11.1% 15.0¢ arovella therapeutics limited

https://seekingalpha.com/news/3440319-aytu-bio-44-percent-zolpimi...

  1. 1,573 Posts.
    lightbulb Created with Sketch. 190
    https://seekingalpha.com/news/3440319-aytu-bio-44-percent-zolpimist-licensing-deal
    Aytu Bio up 44% on ZolpiMist licensing deal

    Mar. 6, 2019 10:45 AM ET|About: Aytu BioScience, Inc. (AYTU)|By: Douglas W. House, SA

    News Editor
    Thinly traded nano cap Aytu BioScience (AYTU +43.6%) is up on a whopping 44x surge in volume in response to its in-licensing partnership with SUDA Pharmaceuticals for the distribution of sleep aid ZolpiMist (zolpidem tartrate oral spray) outside of the U.S. and Canada (Sanofi markets the tablet formulation under the Ambien brand). The companies assumed the license from Magna Pharmaceuticals.

    SUDA will lead development and sublicensing activities. Agreements with "multinational pharmaceutical companies" are already in place in China, Chile, Brazil and throughout Southeast Asia.

    SUDA will pay Aytu a portion of each upfront and milestone payment received from sublicensees in addition to ongoing royalties from net sales.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.0¢
Change
0.015(11.1%)
Mkt cap ! $157.7M
Open High Low Value Volume
14.0¢ 15.0¢ 14.0¢ $106.6K 736.6K

Buyers (Bids)

No. Vol. Price($)
10 487932 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 50000 1
View Market Depth
Last trade - 15.36pm 16/08/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.